Urgent Field Safety Notice for Atellica DCA HbA1c Dx Reagent by Siemens Healthcare Diagnostics Inc. Tarrytown
2023.02.27
Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 03670/23
For further information as well as details concerning the device please see the enclosed Advisory Notice of the manufacturer.